Clinical Trials for Mesothelioma Patients: AZD2171 Contact Information

Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of AZD2171 for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only

California:
City of Hope Comprehensive Cancer Center; 800-826-4673 Contra Costa Regional Medical Center; 925-370-5114 Tower Cancer Research Foundation; 310-888-8680 University of California Davis Cancer; 916-734-3089 USC/Norris Comprehensive Cancer Center; 323-865-0451
Illinois:
Cardinal Bernardin Cancer Center; 708-226-4357 Central Springfield Hematology Oncology Center; 217-525-2500 Decatur Memorial Hospital Cancer Care; 217-876-6601 Evanston Northwestern Healthcare – Evanstown Hospital; 847-570-1381 Ingalls Cancer Care Center at Ingalls Memorial Hospital; 708-915-6747 Oncology Hematology Associates of Central Illinois, PC; 309-243-1000 University of Chicago Cancer Research Center; 773-834-7424
Indiana:
CCOP - Northern Indiana CR Consortium; 574-647-3353 Fort Wayne Medical Oncology and Hematology; 260-484-8830
Michigan:
Oncology Care Associates, PLLC; 269-985-0029
Pennsylvania:
Penn State Cancer Institute at Milton; 717-531-3779
Wisconsin:
Medical College of Wisconsin Cancer Center; 414-805-4380
Toronto, Ontario (Canada):
Princess Margaret Hospital: 416-946-4645

Courtesy of ClinicalTrials.gov,

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney